Next Article in Journal
Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects
Next Article in Special Issue
The Therapeutic Potential of Naringenin: A Review of Clinical Trials
Previous Article in Journal
Brain Iron Homeostasis: A Focus on Microglial Iron
Previous Article in Special Issue
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessArticle
Pharmaceuticals 2018, 11(4), 130; https://doi.org/10.3390/ph11040130

Cereus jamacaru D.C. Hydroalcoholic Extract Promotes Anti-Cytotoxic and Antitumor Activity

1
Laboratório de Genética Vegetal e Toxicológica, Departamento de Ciências Biológicas, Universidade Federal do Espírito Santo, Vitória 29075-910, Brazil
2
Laboratório de Biologia Molecular e Expressão Gênica, Departamento de Ciências Biológicas, Universidade Federal de Alagoas, Arapiraca 57309-005, Brazil
3
Instituto Federal do Espírito Santo, Vila Velha 29106-010, Brazil
4
Laboratório de Química de Produtos Naturais, Departamento de Ciências Farmacêuticas—Universidade Federal do Espírito Santo, Vitória 29040-090, Brazil
*
Author to whom correspondence should be addressed.
Received: 17 October 2018 / Revised: 14 November 2018 / Accepted: 14 November 2018 / Published: 23 November 2018
(This article belongs to the Special Issue Plant Phytochemicals on Drug Development)
Full-Text   |   PDF [728 KB, uploaded 23 November 2018]   |  

Abstract

Cereus jamacaru D.C. (mandacaru) is a cactus used as food and in the traditional medicine. In the present study, hydroalcoholic extract of C. jamacaru was evaluated for its chemical composition, antioxidant activity, cytotoxic and anti-cytotoxic effects in human lymphocytes and sarcoma 180 cells in vitro by MTT assay and antitumoral, mutagenic and cytotoxic effects on mice sarcoma-induced in vivo. Phytochemical characterization showed positive reactions for coumarin, flavanol and tyramine and total flavonoid content of 0.51 µg/mL. C. jamacaru showed antioxidant activity following DPPH (EC50 = 427.74 µg/mL), ABTS (EC50 = 270.57 µg/mL) and Fe2+ chelating ions assays (EC50 = 41.18 µg/mL). C. jamacaru induced significant decrease of sarcoma 180 viability at 24 h and 48 h of treatment, did not induce cytotoxicity in human lymphocytes and inhibits the cytotoxicity of cisplatin in vitro. Following in vivo assays, C. jamacaru promoted tumor reduction (86.07% of tumor inhibition), without inducing mutagenic or cytotoxic damage on mice blood cells. We propose that phenolic and alkaloid compounds in the extract are related to antioxidant activity, increasing its ability in metal chelating activity and promoting anti-cytotoxic activity against cisplatin, as well as these compounds may act on the cell cycle of the tumor cells in vitro and in vivo, leading to anticancer effects and tumor reduction. View Full-Text
Keywords: mandacaru; phytochemistry; antioxidant activity; MTT assay; sarcoma 180 antitumor mandacaru; phytochemistry; antioxidant activity; MTT assay; sarcoma 180 antitumor
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Vencioneck Dutra, J.C.; Moisés Ferreira, J.; Costalonga Pereira, P.R.; Ben-Hur de Oliveira, J.; Vitorino Gervásio, S.; Bernardes Xavier, M.; Mantovanelli da Mota, M.; Luz, A.C.; Rodrigues Pretti, I.; Seibert França, H.; Masrouah Jamal, C.; Pimentel Batitucci, M.C. Cereus jamacaru D.C. Hydroalcoholic Extract Promotes Anti-Cytotoxic and Antitumor Activity. Pharmaceuticals 2018, 11, 130.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top